| mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
9e-05 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
| mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0003 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0004 |
| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0006 |
| mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0007 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.16 |
0.001 |